COPJ moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend. In 30 of 32 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COPJ as a result. In 49 of 60 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The 10-day moving average for COPJ crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where COPJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for COPJ entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for COPJ's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where COPJ advanced for three days, in 209 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
COPJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
SLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 32 of 36 cases where SLS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on SLS as a result. In 72 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
The Moving Average Convergence Divergence (MACD) for SLS just turned positive on October 21, 2026. Looking at past instances where SLS's MACD turned positive, the stock continued to rise in 34 of 39 cases over the following month. The odds of a continued upward trend are 87%.
Following a +15.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where SLS advanced for three days, in 244 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for SLS crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for SLS entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.651) is normal, around the industry mean (2.973). SLS has a moderately low P/E Ratio (-51.591) as compared to the industry average of (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. SLS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 89 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
SLS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 89 | |
SMR RATING 1..100 | 97 | |
PRICE GROWTH RATING 1..100 | 34 | |
P/E GROWTH RATING 1..100 | 30 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| COPJ | SLS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | N/A |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 89% |
| Momentum ODDS (%) | 1 day ago 82% | 1 day ago 88% |
| MACD ODDS (%) | N/A | 1 day ago 87% |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 85% |
| Advances ODDS (%) | 18 days ago 89% | 2 days ago 87% |
| Declines ODDS (%) | 1 day ago 83% | 7 days ago 84% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 89% |
| Aroon ODDS (%) | 1 day ago 81% | 1 day ago 85% |
A.I.dvisor indicates that over the last year, COPJ has been loosely correlated with MTAL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if COPJ jumps, then MTAL could also see price increases.
| Ticker / NAME | Correlation To COPJ | 1D Price Change % | ||
|---|---|---|---|---|
| COPJ | 100% | -5.80% | ||
| MTAL - COPJ | 59% Loosely correlated | -0.45% | ||
| NAK - COPJ | 52% Loosely correlated | -6.14% | ||
| CVV - COPJ | 30% Poorly correlated | -0.26% | ||
| SLS - COPJ | 23% Poorly correlated | -6.51% | ||
| OM - COPJ | 17% Poorly correlated | +2.96% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NURE | 31.69 | 0.57 | +1.82% |
| Nuveen Short-Term REIT ETF (NURE) | |||
| DFAR | 25.03 | 0.36 | +1.46% |
| DFA Real Estate Securities Portfolio: ETF Class Shares (DFAR) | |||
| ZTR | 6.46 | 0.03 | +0.47% |
| Virtus Total Return Fund | |||
| ITDE | 39.90 | -0.34 | -0.84% |
| iShares LifePath Target Date 2045 ETF USD (ITDE) | |||
| WLDU | 16.62 | -0.54 | -3.14% |
| Leverage Shares 2x Long World Stock Daily ETF | |||